Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety of Denufosol in Pediatric Cystic Fibrosis (2-4 Years)
NCT01181622Phase 2Completed
- Sponsor
- Merck & Co.
- Start
- Aug 2010
- Primary completion
- Oct 2010
- Modality
- Small Molecules
01
Overview
A Phase 2 trial of denufosol tetrasodium in cystic fibrosis (CF), sponsored by Merck & Co.. Started Aug 2010; status: completed.
02
Drugs
denufosol tetrasodium
03
Conditions
cystic fibrosis (CF)
Beyond the preview
Go deeper on NCT01181622.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01181622.